Published in FEBS Lett on April 08, 2016
MAVS-dependent host species range and pathogenicity of human hepatitis A virus. Science (2016) 1.49
Hepatocarcinogenesis associated with hepatitis B, delta and C viruses. Curr Opin Virol (2016) 0.79
Viral-host interaction in kidney reveals strategies to escape host immunity and persistently shed virus to the urine. Oncotarget (2016) 0.75
Hitting the right button: MAVS-mediated defense against HAV infection. Cell Res (2016) 0.75
Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate. Cell (1982) 16.71
A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci U S A (1978) 8.92
Replication of hepatitis C virus. Nat Rev Microbiol (2007) 8.31
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature (2009) 8.05
Hepatitis B virus biology. Microbiol Mol Biol Rev (2000) 7.58
Hepatitis B virus infection. N Engl J Med (2008) 6.92
Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol (1984) 6.90
Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell (1986) 6.12
Hepatitis C virus replication in mice with chimeric human livers. Nat Med (2001) 5.87
High-level hepatitis B virus replication in transgenic mice. J Virol (1995) 5.81
Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence. J Virol (1982) 5.48
HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (1991) 5.34
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife (2012) 5.18
Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol (2007) 5.04
The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med (1998) 4.48
CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol (2003) 4.42
Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis (1980) 4.28
Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol (1990) 4.26
Current and future therapies for hepatitis C virus infection. N Engl J Med (2013) 4.25
Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells. J Virol (2003) 4.06
Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol (2006) 3.84
Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology (2005) 3.72
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci U S A (2006) 3.69
Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J Virol (2007) 3.57
Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol (2012) 3.41
Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature (2013) 3.39
Protein covalently bound to minus-strand DNA intermediates of duck hepatitis B virus. J Virol (1983) 3.35
A genetically humanized mouse model for hepatitis C virus infection. Nature (2011) 3.15
Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clin Invest (2010) 3.10
Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology (2002) 3.02
Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J Virol (1986) 2.94
In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology (1990) 2.76
Mapping of the cohesive overlap of duck hepatitis B virus DNA and of the site of initiation of reverse transcription. J Virol (1984) 2.72
Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology (2001) 2.71
Genetic variability in hepatitis B viruses. J Gen Virol (2002) 2.45
Control of cccDNA function in hepatitis B virus infection. J Hepatol (2009) 2.41
Hepatitis delta virus. Lancet (2011) 2.32
Hepatitis B therapy. Nat Rev Gastroenterol Hepatol (2011) 2.23
Characterization of a canine homolog of hepatitis C virus. Proc Natl Acad Sci U S A (2011) 2.14
A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology (2011) 2.06
The reconstituted 'humanized liver' in TK-NOG mice is mature and functional. Biochem Biophys Res Commun (2011) 2.02
Therapy for hepatitis C--the costs of success. N Engl J Med (2014) 1.96
Toward a surrogate model for hepatitis C virus: An infectious molecular clone of the GB virus-B hepatitis agent. Virology (1999) 1.95
Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res (2001) 1.91
A critical role for the chimpanzee model in the study of hepatitis C. Hepatology (2004) 1.90
Replication of a hepatitis C virus replicon clone in mouse cells. Virol J (2006) 1.90
Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages. PLoS Pathog (2014) 1.88
Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator. Cell (1990) 1.83
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J Clin Invest (2012) 1.81
Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology (1996) 1.80
Serology-enabled discovery of genetically diverse hepaciviruses in a new host. J Virol (2012) 1.80
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci U S A (2009) 1.74
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat Biotechnol (2008) 1.70
Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. J Hepatol (2011) 1.70
Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model. Proc Natl Acad Sci U S A (2007) 1.69
The ins and outs of hepatitis C virus entry and assembly. Nat Rev Microbiol (2013) 1.69
Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide. PLoS Pathog (2015) 1.66
Mouse hepatic cells support assembly of infectious hepatitis C virus particles. Gastroenterology (2011) 1.64
Identification of rodent homologs of hepatitis C virus and pegiviruses. MBio (2013) 1.61
Involvement of host cellular multivesicular body functions in hepatitis B virus budding. Proc Natl Acad Sci U S A (2007) 1.49
Animal models for the study of hepatitis C virus infection and related liver disease. Gastroenterology (2012) 1.47
Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice. J Virol (2001) 1.43
Detection of zoonotic pathogens and characterization of novel viruses carried by commensal Rattus norvegicus in New York City. MBio (2014) 1.41
Hepatitis C virus host cell entry. Curr Opin Virol (2012) 1.41
Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections. Hepatology (1989) 1.39
Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis. Curr Top Microbiol Immunol (1996) 1.36
Towards a small animal model for hepatitis C. EMBO Rep (2009) 1.34
Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J Virol (2001) 1.33
The pathophysiology and treatment of hereditary tyrosinemia type 1. Semin Liver Dis (2001) 1.32
Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide. J Virol (2014) 1.27
Broadly neutralizing antibodies abrogate established hepatitis C virus infection. Sci Transl Med (2014) 1.22
Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes. Proc Natl Acad Sci U S A (2013) 1.19
Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice. Am J Pathol (2009) 1.18
Pathogenesis of hepatitis C virus infection in Tupaia belangeri. J Virol (2010) 1.17
Animal models for hepatitis C. Curr Top Microbiol Immunol (2013) 1.17
Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide. J Virol (2013) 1.16
Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans. Hepatology (2000) 1.12
Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity. Methods Mol Biol (2010) 1.11
Epidemiology of hepatitis D. Semin Liver Dis (2012) 1.09
Development of a novel system to study hepatitis delta virus genome replication. J Virol (2005) 1.09
Identification of a pegivirus (GB virus-like virus) that infects horses. J Virol (2013) 1.08
Inhibition of cytochrome c release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins. J Biol Chem (2001) 1.05
Impaired clearance of virus-infected hepatocytes in transgenic mice expressing the hepatitis C virus polyprotein. Gastroenterology (2004) 1.04
Extensive double humanization of both liver and hematopoiesis in FRGN mice. Stem Cell Res (2014) 1.04
Nucleoporin 153 arrests the nuclear import of hepatitis B virus capsids in the nuclear basket. PLoS Pathog (2010) 1.04
Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules. J Virol (2013) 1.03
Clinical course of infection and viral tissue tropism of hepatitis C virus-like nonprimate hepaciviruses in horses. Hepatology (2015) 1.02
Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study. J Viral Hepat (2011) 0.99
Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection. J Hepatol (2013) 0.99
Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I. Mol Genet Metab (2002) 0.99
New antiviral agents for hepatitis C. F1000 Biol Rep (2012) 0.98
Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model. J Clin Invest (2014) 0.97
Efficient infection of tree shrew (Tupaia belangeri) with hepatitis C virus grown in cell culture or from patient plasma. J Gen Virol (2007) 0.97
Virology of hepatitis D virus. Semin Liver Dis (2012) 0.96
Lipid metabolism and HCV infection. Viruses (2010) 0.96
Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model. Antiviral Res (2004) 0.96
Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines. PLoS Pathog (2011) 0.95
A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections. Biochem Biophys Res Commun (2013) 0.95
A mouse model for HBV immunotolerance and immunotherapy. Cell Mol Immunol (2013) 0.93
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines. Virology (2013) 0.93